Effects of dl‐3‐n‐butylphthalide on serum lipoprotein‐associated phospholipase A2 and hypersensitive C‐reactive protein levels in acute cerebral infarction

Effects of dl‐3‐n‐butylphthalide on serum lipoprotein‐associated phospholipase A2 and hypersensitive C‐reactive protein levels in acute cerebral infarction

Abstract Objective This study aims to explore the curative effect of dl‐3‐n‐butylphthalide (NBP) on patients with acute cerebral infarction (ACI) and its effects on serum lipoprotein‐associated phospholipase A2 (Lp‐PLA2) and hypersensitive C‐reactive protein (hs‐CRP) levels. Methods A total of 136 A...

Full description

Bibliographic Details
Main Authors:	Xiao‐Lei Zhang, Yin‐Tao Dong, Yi Liu, Yi Zhang, Ting‐Ting Li, Feng‐Yun Hu
Format:	Article
Language:	English
Published:	Wiley 2019-12-01
Series:	Brain and Behavior
Subjects:	acute cerebral infarction butylphthalide hypersensitive C‐reactive protein lipoprotein‐associated phospholipase A2
Online Access:	https://doi.org/10.1002/brb3.1469

Similar Items

Effectiveness of alteplase intravenous thrombolysis combined with butylphthalide in patients with acute severe cerebral infarction
by: Zhengqian Wang, et al.
Published: (2022-12-01)

Effect of butylphthalide on prevention and treatment of high altitude cerebral edema in rats
by: Bohua Ma, et al.
Published: (2024-03-01)

Effect of Dl-3-n-Butylphthalide on olfaction in rotenone-induced Parkinson’s rats
by: Jiawei Wang, et al.
Published: (2024-04-01)

Effect of Dl-3-n-butylphthalide on mitochondrial Cox7c in models of cerebral ischemia/reperfusion injury
by: Jingjing Jia, et al.
Published: (2023-02-01)

Effects of Dl-3-n-butylphthalide on neurological function, hemodynamics and Hcy concentration in cerebral hemorrhage: a systematic review and meta-analysis
by: Yingqi Ma, et al.
Published: (2024-05-01)

Effects of butylphthalide sodium chloride injection combined with edaravone dexborneol on neurological function and serum inflammatory factor levels in sufferers having acute progressive cerebral infarction
by: Yaqiang Li, et al.
Published: (2024-12-01)

DL-3-n-butylphthalide improves cerebral hypoperfusion in patients with large cerebral atherosclerotic stenosis: a single-center, randomized, double-blind, placebo-controlled study
by: Dawei Chen, et al.
Published: (2020-05-01)

Clinical efficacy analysis of butylphthalide combined with urinary kallidinogenase in treating chronic cerebral circulatory insufficiency
by: Bo Hu, et al.
Published: (2023-04-01)

Dl-3-n-Butylphthalide Treatment Enhances Hemodynamics and Ameliorates Memory Deficits in Rats with Chronic Cerebral Hypoperfusion
by: Zhilin Xiong, et al.
Published: (2017-07-01)

Neuroprotective effect and mechanism of butylphthalide after cerebral ischemia-reperfusion injury in rats
by: Shan Shan Huang, et al.
Published: (2021-06-01)

Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion
by: Ting Zhu, et al.
Published: (2024-02-01)

Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
by: Xiaojiu Zhang, et al.
Published: (2022-12-01)

Plasma Lipoprotein-Associated Phospholipase A2 Affects Cognitive Impairment in Patients with Cerebral Microbleeds
by: Liu L, et al.
Published: (2023-03-01)

Dl-3-n-Butylphthalide Reduced Neuroinflammation by Inhibiting Inflammasome in Microglia in Mice after Middle Cerebral Artery Occlusion
by: Mengdi Liu, et al.
Published: (2022-08-01)

Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis
by: Xiaochao Tian, et al.
Published: (2017-06-01)

Spatial metabolic analysis of the regulatory effects of DL-3-n-butylphthalide in a cerebral ischemia-reperfusion mouse model
by: Yuxuan Lu, et al.
Published: (2025-03-01)

Dl-3-n-Butylphthalide Alleviates Hippocampal Neuron Damage in Chronic Cerebral Hypoperfusion via Regulation of the CNTF/CNTFRα/JAK2/STAT3 Signaling Pathways
by: Wenxian Li, et al.
Published: (2021-01-01)

DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials
by: Huan Wang, et al.
Published: (2022-09-01)

DL-3n-Butylphthalide Improves Blood–Brain Barrier Integrity in Rat After Middle Cerebral Artery Occlusion
by: Muyassar Mamtilahun, et al.
Published: (2021-01-01)

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
by: Yanmin Chang, et al.
Published: (2021-02-01)

The neuroprotective effect of Dl-3-n-butylphthalide in epileptic rats via inhibiting endoplasmic reticulum stress
by: Shuang Tian, et al.
Published: (2023-01-01)

Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
by: Yajing Chen, et al.
Published: (2019-02-01)

Corrigendum: Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
by: Yanmin Chang, et al.
Published: (2021-06-01)

Unveiling the potential of Butylphthalide: inhibiting osteoclastogenesis and preventing bone loss
by: Feng Yanbin, et al.
Published: (2024-02-01)

DL-3-n-butylphthalide promotes hippocampal neurogenesis and reduces mossy fiber sprouting in chronic temporal lobe epilepsy rats
by: Shanshan Zhao, et al.
Published: (2022-01-01)

DL-3-n-butylphthalide enhances synaptic plasticity in mouse model of brain impairments
by: Qian Ding, et al.
Published: (2022-01-01)

Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
by: Yajing Chen, et al.
Published: (2021-07-01)

DL-3-n-Butylphthalide Attenuates Myocardial Hypertrophy by Targeting Gasdermin D and Inhibiting Gasdermin D Mediated Inflammation
by: Bingjiang Han, et al.
Published: (2021-06-01)

Impacts of N-Butylphthalide on expression of growth factors in rats with focal cerebral ischemia
by: Yan Jiang, et al.
Published: (2016-01-01)

DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress
by: Hui Zhang, et al.
Published: (2023-01-01)

Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice
by: Jiahui Wang, et al.
Published: (2021-09-01)

Butylphthalide Inhibits Autophagy and Promotes Multiterritory Perforator Flap Survival
by: Baolong Li, et al.
Published: (2021-01-01)

Clinical Utility of the Serum Level of Lipoprotein-Related Phospholipase A2 in Acute Ischemic Stroke With Cerebral Artery Stenosis
by: Jing Cao, et al.
Published: (2021-03-01)

DL-3-n-butylphthalide attenuates doxorubicin-induced acute cardiotoxicity via Nrf2/HO-1 signaling pathway
by: Dengke Li, et al.
Published: (2024-03-01)

脑梗死急性期使用丁苯酞注射液对患者脑血流灌注和认知功能的影响 Effects of Butylphthalide Injection on Cerebral Perfusion and Cognitive Function in Patients with Acute Cerebral Infarction
by: 邬刚, 战丽萍, 安明顺, 李妍平, 李杨, 涂坤, 王晋
Published: (2018-09-01)

Long-Term DL-3-n-Butylphthalide Treatment Alleviates Cognitive Impairment Correlate With Improving Synaptic Plasticity in SAMP8 Mice
by: Chaonan Lv, et al.
Published: (2018-07-01)

Protective effects of 3-n-butylphthalide on cerebral infarction induced by local ischemic injury and regulation mechanism of the pi3k/akt/gsk- 3β signaling pathway
by: Ke LI, et al.
Published: (2023-01-01)

Efficacy and Safety of DL-3-n-Butylphthalide in the Treatment of Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis
by: Xueming Fan, et al.
Published: (2022-01-01)

Lipoprotein-associated phospholipase A2 is increased in patients with impaired bone density
by: Kotaška Karel, et al.
Published: (2014-01-01)

Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
by: Yun Qian, et al.
Published: (2019-12-01)